€71.15
1.64% day before yesterday
Xetra, Dec 27, 05:35 pm CET
ISIN
DE000A0LD6E6
Symbol
GXI
Index
Industry

Gerresheimer Stock price

€71.15
-2.80 3.79% 1M
-30.15 29.76% 6M
-23.20 24.59% YTD
-24.80 25.85% 1Y
-13.25 15.70% 3Y
+1.60 2.30% 5Y
+25.84 57.01% 10Y
Xetra, Closing price Fri, Dec 27 2024
+1.15 1.64%
ISIN
DE000A0LD6E6
Symbol
GXI
Index
Industry

Key metrics

Market capitalization €2.46b
Enterprise Value €3.63b
P/E (TTM) P/E ratio 21.50
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.81
P/S ratio (TTM) P/S ratio 1.22
P/B ratio (TTM) P/B ratio 1.72
Dividend yield 1.76%
Last dividend (FY23) €1.25
Revenue growth (TTM) Revenue growth 1.93%
Revenue (TTM) Revenue €2.01b
EBIT (operating result TTM) EBIT €227.30m
Free Cash Flow (TTM) Free Cash Flow €-120.48m
Cash position €109.45m
EPS (TTM) EPS €3.31
P/E forward 19.65
P/S forward 1.20
EV/Sales forward 1.78
Show more

Is Gerresheimer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Gerresheimer Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Gerresheimer forecast:

15x Buy
94%
1x Hold
6%

Analyst Opinions

16 Analysts have issued a Gerresheimer forecast:

Buy
94%
Hold
6%

Financial data from Gerresheimer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
2,012 2,012
2% 2%
100%
- Direct Costs 1,427 1,427
4% 4%
71%
585 585
2% 2%
29%
- Selling and Administrative Expenses 145 145
1% 1%
7%
- Research and Development Expense 19 19
0% 0%
1%
422 422
3% 3%
21%
- Depreciation and Amortization 194 194
3% 3%
10%
EBIT (Operating Income) EBIT 227 227
8% 8%
11%
Net Profit 114 114
6% 6%
6%

In millions EUR.

Don't miss a Thing! We will send you all news about Gerresheimer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Gerresheimer Stock News

AD HOC NEWS
6 days ago
Das US-Analysehaus Bernstein Research hat Gerresheimer DE000A0LD6E6 auf "Outperform" mit einem Kursziel von 100,30 Euro belassen.
AD HOC NEWS
9 days ago
Die US-Bank JPMorgan hat die Einstufung für Gerresheimer DE000A0LD6E6 auf "Overweight" mit einem Kursziel von 111,40 Euro belassen.
AD HOC NEWS
9 days ago
Das Analysehaus Jefferies hat die Einstufung für Gerresheimer DE000A0LD6E6 mit einem Kursziel von 93 Euro auf "Buy" belassen.
More Gerresheimer News

Company Profile

Gerresheimer AG manufactures and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices; Primary Packaging Glass; and Head Office. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The company was founded on November 3, 2004 and is headquartered in Duesseldorf, Germany.

Head office Germany
CEO Dietmar Siemssen
Employees 11,660
Founded 1864
Website www.gerresheimer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today